Friday, July 31, 2026

Monica’s Manus AI: State-of-the-Art or Still a Work in Progress?

Manus AI's launch has sparked excitement and skepticism, revealing impressive coding but limited virtual assistant capabilities.

How Celltrion’s Omlyclo is Dominating Spain’s Omalizumab Market: A First-Mover Success Story

Celltrion's Omlyclo treatment is thriving in Spain, capturing over 60% of the omalizumab market with innovative strategies and strong demand.

‘Do they still have Future?’: North Korea Celebrates 80 Years of the Workers’ Party

North Korea intensifies propaganda for the Workers' Party's 80th anniversary, emphasizing self-reliance and national defense amidst global challenges.

Tag: Neok Bio

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

ABL Bio to Invest Additional $25 Million in Neok Bio to Accelerate ADC Clinical Trials

ABL Bio invests $25M in Neok Bio for bispecific antibody-drug conjugate trials, aiming for FDA-approved treatments by 2027.

Unlocking Cancer Treatment: ABL206 and ABL209’s Promising Non-Clinical Data Revealed at AACR

ABL Bio will present preclinical data for its ADCs ABL206 and ABL209 at AACR 2023, showcasing promising anti-cancer efficacy.

ABL206: First-in-Class Dual Antibody Drug Conjugate Approved for Clinical Trials in the U.S. – What This Means for Cancer Treatment

ABL Bio and Neok Bio received FDA approval for ABL206, a dual-antibody ADC, marking a key milestone in their clinical development efforts.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.